Clinical & Interventional Cardiology
|
|
- Brendan Julius Williams
- 8 years ago
- Views:
Transcription
1 Endorsed by Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC ADVANCE PROGRAM 1
2 PRESIDENT Michele M. Gulizia, MD, FESC ORGANIZED BY Cardiology Division Garibaldi-Nesima Hospital Catania, Italy SCIENTIFIC SECRETARIAT Michele M. Gulizia Director Cardiology Division Garibaldi-Nesima Hospital - Catania, Italy CONGRESS VENUE Sheraton Catania Hotel & Conference Center Via Antonello da Messina, 45 Aci Castello - Catania, Italy OFFICIAL LANGUAGES The Meeting s official languages are English and Italian (simultaneous translation will be provided). Dear Colleagues and Friends, I would like to invite you to attend the 7th edition of the Mediterranean Cardiology Meeting (MCM), April 18-20, in Catania (Italy). Over 1200 participants attended our last meeting with also strong international participation which confirmed the highest interest aroused by this biannual meeting. An outstanding Faculty, selected between the leading experts on these fields, will provide the highest quality teaching with new interactive programs and happenings. Thorough multidisciplinary Courses, Symposia, Debates on Controversial Topics, Clinical Tutorials, Luncheon Panels, Focus on, Meet-the-Expert Sessions, Interactive Cases-Review from Faculty and Attendance, Televoter Sessions, Intercultural Exchanges, Abstract and Poster Sessions the meeting will highlight the current state and the prospective developments for the treatment of: Atrial Fibrillation, Sudden Cardiac Death, Heart Failure, Acute Coronary Syndromes, Global Cardiovascular Prevention, Arterial Hypertension, Pharmacological Therapy, Syncope, Congenital Heart Disease, Cardiac Monitoring Technologies and Genetics. The main target of the meeting is to give the latest update on Clinical & Interventional Cardiology and it is addressed to cardiologists, internists, first aid clinicians, physicians of general medicine, fellows, nurses and technicians with high interest in the whole management of cardiac pathologies. Catania, as one of the most famous historical and cultural locations in the whole Mediterranean area, is the ideal setting for this meeting. It is a particularly lively and fascinating town, rich in marvellous examples of typically Sicilian baroque style, as well as one of the main economic and educational centres in the island, and a key hub of the technological industry. This beautiful city, full of colours, perfumes and flavours, is suspended between the deep blue of the Ionian Sea and the majestic shape of Etna volcano, which dominates the town from afar. Looking forward to seeing you in Catania, sincerely Michele M. Gulizia, MD, FESC President Mediterranean Cardiology Meeting 1
3 Scientific Committee Angelo Auricchio (Switzerland) Gianluca Botto (Italy) Eugene Braunwald (USA) Michele Brignole (Italy) Joseph Brugada (Spain) Riccardo Cappato (Italy) Paul Casale (USA) Matteo Di Biase (Italy) Giuseppe Di Pasquale (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Karl Heinz Kuck (Germany) Organizing Committee Michele M. Gulizia Mario Audoly Concetto Cacia Nunzia R. Cardillo Giuseppe Di Guardo Giuseppina Maura Francese Cardiology Division Ga r i b a l d i - Ne s i m a Ho s p i ta l - Cata n i a, Ita ly Advisory Board Maurizio Abrignani (Italy) Gianfranco Alunni (Italy) Antonio F. Amico (Italy) Fabrizio Ammirati (Italy) Angelo Auricchio (Switzerland) Alessandro Biffi (Italy) Giuseppe Boriani (Italy) Gianluca Botto (Italy) Michele Brignole (Italy) Joseph Brugada (Spain) Pasquale Caldarola (Italy) Valeria Calvi (Italy) Salvatore Campione (Italy) Roberto Caporale (Italy) Riccardo Cappato (Italy) Paul Casale (USA) Giancarlo Casolo (Italy) Domenico Catanzariti (Italy) Giacomo Chiarandà (Italy) Gennaro Cice (Italy) Furio Colivicchi (Italy) Pietro Delise (Italy) Matteo Di Biase (Italy) Andrea Di Lenarda (Italy) Giuseppe Di Pasquale (Italy) Giuseppe Di Tano (Italy) Francesco Furlanello (Italy) Domenico Gabrielli (Italy) Angelo Gambera (Italy) Gianfranco Gensini (Italy) Giovanna Geraci (Italy) Franco Giada (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Giuseppe Inama (Italy) Helmut Klein (Germany) Karl Heinz Kuck (Germany) Maurizio Eugenio Landolina (Italy) Maurizio Lunati (Italy) Aldo P. Maggioni (Italy) Attilio Maseri (Italy) Jay Metha (USA) Andrea Natale (USA) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Fausto J. Pinto (Portugal) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Marino Scherillo (Italy) Daniele Mangiameli Anna Portale Salvatore Raciti Natascia Savoca Silvana Anastasi Giuseppe Di Dio Giuditta Gianì Aldo Pietro Maggioni (Italy) Attilio Maseri (Italy) Anna Vittoria Mattioli (Italy) Gianfranco Mazzotta (Italy) Jay Metha (USA) Vincenzo Montemurro (Italy) Loredana Morichelli (Italy) Ernesto Mossuti (Italy) Franco Naccarella (Italy) Federico Nardi (Italy) Andrea Natale (USA) Salvatore Novo (Italy) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Giuseppe Palazzo (Italy) Vittorio Panno (Italy) Leonardo Patanè (Italy) Pasquale Perrone Filardi (Italy) Fausto J. Pinto (Portugal) Salvatore Pirelli (Italy) Calogero Puntrello (Italy) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Carmine Riccio (Italy) Carla Riganti (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Maurizio Santomauro (Italy) Marino Scherillo (Italy) Gianfranco Sinagra (Italy) Christian Sticherling (Switzerland) Corrado Tamburino (Italy) Pier Luigi Temporelli (Italy) Sakis Themistoclakis (Italy) Salvatore Tolaro (Italy) Giovanni Battista Zito (Italy) Massimo Zoni Berisso (Italy) Guerrino Zuin (Italy) Allied Professionals Course Coordinators Giuseppina Maura Francese (Italy), Angelo Gambera (Italy), Loredana Morichelli (Italy) Endorsed by: 2 3 ENDORSEMENT & AUSPICES EHRA - European Heart Rhythm Association, a Registered Branch of the ESC FIC - Federazione Italiana di Cardiologia WSA - World Society of Arrhythmias Under the auspices of: AIAC - Associazione Italiana di Aritmologia e Cardiostimolazione ANCE - Associazione Italiana Cardiologi Extraospedalieri ANMCO - Associazione Nazionale Medici Cardiologi Ospedalieri ARCA - Associazioni Regionali Cardiologi Ambulatoriali AA Arrhythmia Alliance ECAS - European Cardiac Arrhythmia Society GIEC - Gruppo Intervento Emergenze Cardiologiche GISE - Società Italiana di Cardiologia Invasiva ISE - International Society of Electrocardiology SIC - Società Italiana di Cardiologia SIC SPORT - Società Italiana di Cardiologia dello Sport SOLAECE - Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia
4 FACULTY M. Abrignani (Trapani, Italy) G. Agnelli (Perugia, Italy) F. Ammirati (Ostia, Italy) S. Berti (Massa, Italy) M. Biffi (Bologna, Italy) L. Bolognese (Arezzo, Italy) G. Boriani (Bologna, Italy) D. Brancaccio (Milan, Italy) L. Calò (Rome, Italy) D. Capodanno (Catania, Italy) R. Caporale (Cosenza, Italy) A. Capucci (Ancona, Italy) G. Casolo (Viareggio, Italy) G. Casu (Nuoro, Italy) G. Ciaramitaro (Palermo, Italy) G. Cice (Naples, Italy) F. Colivicchi (Rome, Italy) C. Cuccia (Brescia, Italy) A. Curcio (Catanzaro, Italy) P. Delise (Conegliano Veneto, Italy) L. De Luca (Rome, Italy) L. De Nicola (Naples, Italy) A. Di Lenarda (Trieste, Italy) G. Di Pasquale (Bologna, Italy) G. Geraci (Palermo, Italy) U. Giordano (Palermo, Italy) C. Greco (Rome, Italy) M. M. Gulizia (Catania, Italy) G. Iervasi (Pisa, Italy) T. Infusino (Catanzaro, Italy) M. Landolina (Milan, Italy) M. Lunati (Milan, Italy) G. Luzzi (Bari, Italy) A.P. Maggioni (Florence, Italy) E. Manzato (Padova, Italy) A. Margonato (Milan, Italy) C. Martignani (Bologna, Italy) G. Mazzotta (La Spezia, Italy) V. Montemurro (Reggio Calabria, Italy) L. Morichelli (Rome, Italy) G. Mureddu (Rome, Italy) S. Novo (Palermo, Italy) E. Occhetta (Novara, Italy) R.A. Osanna (Potenza, Italy) P. Perrone Filardi (Naples, Italy) E. Pisanò (Lecce, Italy) A. Rapacciuolo (Naples, Italy) C. Rapezzi (Bologna, Italy) A. Raviele (Mestre, Italy) R.P. Ricci (Rome, Italy) F. Romeo (Rome, Italy) R. Rossini (Bergamo, Italy) M. Scherillo (Benevento, Italy) L. Testa (Milan, Italy) M. Uguccioni (Rome) S. Urbinati (Bologna, Italy) R. Verlato (Camposampiero, Italy) S. Viani (Pisa, Italy) PROGRAM AT A GLANCE This faculty list may change due to pending confirmation from invited speakers. 4 5
5 PROGRAM AT A GLANCE SATURDAY APRIL 18 Sat, April 18 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room Registration Registration Allied Professional Registration Registration Minicourse Aortic valve pathology today Interactive Minicourse Risk Stratification in Primary Prevention Allied Professional Program Nursing management of cardiovascular drugs Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break Focus on Discovering the second generation of S-ICD Controversies on Dronedarone: Guide Lines and Therapeutic Plan, a glaring dichotomy between Clinical Evidences and Regulatory restrictions Interactive Symposium The management of the patient with Stable CAD: the benefits of the new therapeutic approach Allied Professional Program Organizational aspects and management in arrhythmology - Nursing in hemodynamic Casual Morning Meeting Navigating the evidence: are all NOACs the same? Hyperphosphatemia: a real double-face matter? Luncheon Panel Interactive Luncheon Panel Different therapeutical approach in patients with NSTEMI PCI and in those with pharmacological therapy Casual Meeting The revolution of biological drugs in cardiology: new perspectives for high risk patients Exhibition Visit & Coffee Break ESC-EHRA Joint Symposium Interactive Symposium Rivaroxaban: practical experience examples and sharing clinical cases Allied Professional Program Update in electrophysiology and cardiac pacing - Prevention of infection in cardiology and cardiac surgery Casual Afternoon Meeting Home Monitoring in clinical practice: the role of physician and nurse Plenary Lecture Opening Ceremony 6 7
6 PROGRAM AT A GLANCE SUNDAY APRIL 19 Sun, April 19 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room ECG Corner The Art of the 12-lead ECG. The basis of daily diagnosis interactive resolution of ECG cases Exhibition Visit & Coffee Break Symposium Getting the most out of the latest available technologies in order to optimize daily clinical practice Lecture Therapeutic Target of Uricaemia and impact on Health Care Costs Luncheon Panel Patients with high CV risk and hypercholesterolemia: old unresolved problems, new solutions Interactive Symposium Management of dyslipidemia in high cardiovascular risk patients: two clinical cases Interactive Symposium Unmet needs and current practice of stroke prevention in non valvular atrial fibrillation Interactive Luncheon Panel Exhibition Visit Exhibition Visit Symposium The use of large Registries for Quality Improvement for patients with Coronary Artery Disease or Cardiac Arrhythmias Lecture Thyroid hormone treatment in heart failure: when and how? Lecture Inflammation in atherosclerosis- do we need to treat it? Meet the Expert The Heart in Neoplastic patients Interactive Symposium Novel trials and new horizons with dabigatran: protecting patients at high risk of stroke Interactive Meet the Expert 10 Interactive Question / Answers on Pulmonary Hypertension & Pulmonary Embolism Allied Professional Program NAO in nonvalvular atrial fibrillation Exhibition Visit & Coffee Break Allied Professional Program Joint Session: Education as a tool to enhance the health care allied professionals - Nurse and heart failure Allied Professional Program Nursing care in non-invasive ventilation Lecture A defibrillator to bring down mortality: state of the art (S-ICD) Casual Morning Meeting Longevity, Mini-ICD, S-ICD: the right device for every patient. What is the best choice? Casual Morning Meeting Rivaroxaban: operating instructions Casual Afternoon Meeting Dyslipidemic patients: from acute setting to long term management of cardiovascular risk Casual Afternoon Meeting Management of High Risk Cardiovascular Patients 8 9
7 PROGRAM AT A GLANCE MONDAY APRIL 20 Mon, April 20 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room Minicourse TAVI and MITRACLIP: how to select the Ideal Candidate Interactive Minicourse Pediatric Cardiology: the real needs for daily practice Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break Symposium Which oral antiplatelet agents in ACS-PCI patients? Unmet Needs and Possible Solutions Focus on Chest Pain: do we still need a CP Unit or can we integrate it in Cardiology? Interactive Symposium Heart & Sport: 10 Question / Answers on Cardiac Evaluation at Different Age and Different Sports Lecture Changing the face of anticoagulation: 2 years of Dabigatran in Italy BLS-D Course physician BLS-D Course physician Casual Morning Meeting New perspectives in the prevention of thromboembolic risk in Atrial Fibrillation Casual Morning Meeting Innovation in Arrhythmology Luncheon Panel Interactive Luncheon Panel Lunch Symposium The Management of Antiplatelet and Anticoagulant Therapy in Surgery Focus on ICD implanted patients: balance between Benefit & Complication Interactive Symposium Atrial Fibrillation & Heart Failure Interactive Focus On Do we need Cardiopulmonary Test in All Heart Failure patients? BLS-D Course physician 10 11
8 SCIENTIFIC PROGRAM APRIL 18, Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 12 13
9 SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April Registration Secretariat Desk Interactive Minicourse Etna Room Minicourse Pegaso Room Risk Stratification in Primary Prevention AORTIC VALVE PATHOLOGY TODAY Valvular repair Traditional surgery: which prothesis? TAVI The sutureless 14 15
10 SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April Focus on Pegaso Room Interactive Symposium Etna Room Discovering the second generation of S-ICD Chairmen: U. Giordano (Palermo), E. Occhetta (Novara) Speakers: A. Curcio (Catanzaro), S. Viani (Pisa) The management of the patient with Stable CAD: the benefits of the new therapeutic approach - New ESC guideline 2013: diagnosis and risk stratification - Therapeutic approach in Stable CAD: which news from ANMCO/GICR-IACPR/ GISE Consensus Clinical Cases - Diabetic patient with Stable CAD and with no possible revascularization - Elder patient with previous infarction and Stable CAD with comorbidity - Patient with microvascular angina 16 17
11 SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April Casual Morning Meeting Timo Alto Room Controversies on Pegaso Room Navigating the evidence: are all NOACs the same? Chairmen: F. Romeo (Rome), TBA Stroke prevention in NVAF patients: challenges in clinical practice F. Ammirati (Ostia) Rationale for NOAC dosing strategies: the apixaban case P. Perrone Filardi (Naples) Dronedarone: Guide Lines and Therapeutic Plan, a glaring dichotomy between Clinical Evidences and Regulatory restrictions Chairmen: M.M. Gulizia (Catania), A. Raviele (Mestre) Pro: A. Capucci (Ancona) Cons: G. Boriani (Bologna) HYPERPHOSPHATEMIA: A REAL DOUBLE-FACE MATTER? Chairmen: D. Brancaccio (Milan), TBA - No, It s a pure Kidney disease! L. De Nicola (Naples) - Yes, It s a Kidney-Cardio disease! G. Cice (Naples) 18 19
12 SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April Luncheon Panel Pegaso Room Casual Meeting Timo Alto Room Interactive Luncheon Panel Etna Room Different therapeutical approach in patients with NSTEMI PCI and in those with pharmacological therapy Chairmen: G. Mazzotta (La Spezia), TBA Discerning criteria for choosing reperfusion strategy R.A. Osanna (Potenza) Updates about medical management (of ACS) TBA The revolution of biological drugs in cardiology: new perspectives for high risk patients Chairmen: M.M. Gulizia (Catania), F. Romeo (Rome) Cardiovascular prevention in Italy: where we are today and where we need to be G. Mureddu (Rome) Statin intolerance and adherence management V. Montemurro (Reggio Calabria) Role of PCSK9i in the difficult cardiovascular prevention C. Rapezzi (Bologna) Therapeutic options and prognosis of NSTEMI patient not eligible for invasive strate G. Casolo (Viareggio, LU) 20 21
13 SCIENTIFIC PROGRAM Saturday, April 18 Saturday, April Interactive Symposium Etna Room ESC-EHRA Joint Symposium Pegaso Room Rivaroxaban: real life experience e clinical cases sharing Chairmen: G. Di Pasquale (Bologna), M. Uguccioni (Rome) Evidences from Dresda registry L. Calò (Rome) Interactive discussion of clinical cases in stroke prevention in atrial fibrillation and treatment of pulmonary embolism Casual Meeting Timo Alto Room Home Monitoring in clinical practice: the role of physician and nurse Chairmen: F. Ammirati (Ostia), TBA Speakers: R.P. Ricci (Rome) L. Morichelli (Rome) Atrial Fibrillation clinical cases: First case G. Casu (Nuoro) Second case G. Boriani (Bologna) Pulmonary embolism C. Cuccia (Brescia) 22 23
14 Saturday, April Plenary Lecture Pegaso Room Opening Ceremony Pegaso Room SCIENTIFIC PROGRAM APRIL 19, Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 24 25
15 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April ECG Corner Pegaso Room Interactive Symposium Etna Room The Art of the 12-lead ECG. The basis of daily diagnosis Interactive resolution of ECG cases Management of dyslipidemia in high cardiovascular risk patients: two clinical cases Chairmen: A. Di Lenarda (Trieste), TBA First Clinical Case F. Colivicchi (Rome) Second Clinical Case M. Abrignani (Trapani) Third Clinical Case E. Manzato (Padova) 26 27
16 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Casual Meeting Timo Alto Room Symposium Pegaso Room Longevity, Mini-ICD, S-ICD: the right device for every patient. What is the best choice? Chairman: G. Ciaramitaro (Palermo) Getting the most out of the latest available technologies in order to optimize daily clinical practice Chairmen: P. Delise (Conegliano Veneto, TV), M. Landolina (Milan) Speakers: E. Pisanò (Lecce), G. Luzzi (Bari) Adapting ventricular pacing in order to increase responsiveness to CRT M. Biffi (Bologna) SureScan technology: the ultimate solution for CIED patients undergoing MRI A. Rapacciuolo (Naples) Reveal LINQ: a revolution in subcutaneous cardiac monitoring T. Infusino (Catanzaro) More than AF patients treated with One Shot technology: what we know and what we expect R. Verlato (Camposampiero, PD) 28 29
17 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Interactive Symposium Etna Room Casual Meeting Timo Alto Room Unmet needs and current practice of stroke prevention in non valvular atrial fibrillation Chairmen: S. Novo (Palermo), TBA Translating clinical data in real word use M. Scherillo (Benevento) Rivaroxaban: operating instructions Chairmen: M.M. Gulizia (Catania), A.P. Maggioni (Florence) Speakers: G. Agnelli (Perugia), TBA Interactive case based session R. Caporale (Cosenza), G. Geraci (Palermo) 30 31
18 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Lecture Pegaso Room Luncheon Panel Pegaso Room Therapeutic target of uricaemia and impact on health care costs Patients with high CV risk and hypercholesterolemia: old unresolved problems, new solutions Hypercholesterolemia: what is the real dimension of the problem? Therapeutic inappropriateness and inertia in management of dyslipidemias in patient with high CV risk Treatment of high CV risk patient with hypercholesterolemia: we are close to real innovation Interactive Luncheon Panel Etna Room 32 33
19 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Symposium Pegaso Room Interactive Symposium Etna Room The use of large Registries for Quality Improvement for patients with Coronary Artery Disease or Cardiac Arrhythmias Novel trials and new horizons with dabigatran: protecting patients at high risk of stroke Chairmen: M.M. Gulizia (Catania), TBA First Clinical Case C. Martignani (Bologna) Second Clinical Case A. Margonato (Milan) Third Clinical Case L. Testa (Milan) 34 35
20 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Casual Meeting Timo Alto Room Lecture Pegaso Room Dyslipidemic patients: from acute setting to long term management of cardiovascular risk Chairmen: C. Greco (Rome) Sustainability of statin treatments F. Colivicchi (Rome) Thyroid hormone treatment in heart failure: when and how? Chairman: TBA Speaker: G. Iervasi (Pisa) Statin-beyond LDL control S. Urbinati (Bologna) 36 37
21 SCIENTIFIC PROGRAM Sunday, April 19 Sunday, April Casual Afternoon Meeting Timo Alto Room Lecture Pegaso Room Management of High Risk Cardiovascular Patients Inflammation in atherosclerosis: do we need to treat it? Dyslipidemia treatment after ACS New evidences on the protective role of n-3 PUFAs in patients with ACS Dyslipidemie management in the renal patient 38 39
22 Sunday, April Interactive Meet the expert Etna Room 10 Interactive Question / Answers on PulmOnary Hypertension & PulmOnary Embolism Meet the expert Pegaso Room The Heart in Neoplastic patients SCIENTIFIC PROGRAM APRIL 20, Cardiotoxicity of Anthracycline-like Chemotherapy agents: Cardioprotection and Management Trastuzumab, novel ErbB2 Inhibitors and Antiangiogenic Agents: Cardioprotection and Management of toxicity of Target Therapy Management of Atrial Fibrillation and VTE in Cancer Patients: there is a role for NOAC? QT Monitoring in Chemotherapy and Management of Cardiac Devices during Radiation Therapy Legend PEGASO ROOM ETNA ROOM CALIPSO room TIMO ALTO room 40 41
23 SCIENTIFIC PROGRAM Monday, April 20 Monday, April Minicourse Pegaso Room Casual Morning Meeting Timo Alto Room TAVI and MITRACLIP: how to select the Ideal Candidate Interactive Minicourse Etna Room Pediatric Cardiology: the real needs for daily practice New perspectives in the prevention of thromboembolic risk in Atrial Fibrillation Chairmen: M.M. Gulizia (Catania), TBA Unmet medical needs in the prevention of thromboembolic events in AF M. Lunati (Milan) NOACs in the treatment of AF: Clinical Trials and RWE M. Scherillo (Benevento) The role of NOACs in pts undergoing electrical cardioversion TBA 42 43
24 SCIENTIFIC PROGRAM Monday, April 20 Monday, April Symposium Pegaso Room Interactive Symposium Etna Room WHICH ORAL ANTIPLATELET AGENTS IN ACS-PCI PATIENTS? Unmet Needs and Possible Solutions Heart & Sport: 10 Question / Answers on Cardiac Evaluation at Different Age and Different Sports Chairmen: S. Berti (Massa), TBA The essential need and the right solution for ensuring the best outcome in STEMI patients D. Capodanno (Catania) Current Controversies in the administration of antiplatelet therapy in NSTEMI- PCI: Pretreatment vs Non-Pretreatment, what to do? L. Bolognese (Arezzo) Focus on Pegaso Room Chest Pain: do we still need a CP Unit or can we integrate it in Cardiology? Do SCA-Diabetic patients deserve a more targeted treatment? R. Rossini (Bergamo) Switching: the right strategy to improve patients treatment L. De Luca (Rome) 44 45
25 SCIENTIFIC PROGRAM Monday, April 20 Monday, April Lecture Etna Room Casual Meeting Timo Alto Room Changing the face of anticoagulation: 2 years of Dabigatran in Italy INNOVATION IN ARRHYTHMOLOGY Multi Point Pacing: improving the outcome of the CRT patients Contact Force Sensor: changing the routine of AF ablation procedures Leadless Pacemaker: changing paradigms in bradyarrhythmia treatment 46 47
26 SCIENTIFIC PROGRAM Monday, April 20 Monday, April Luncheon Panel Pegaso Room Interactive Luncheon Panel Etna Room 48 49
27 SCIENTIFIC PROGRAM Monday, April 20 Monday, April Symposium Pegaso Room Focus on Pegaso Room THE MANAGEMENT OF ANTIPLATELET AND ANTICOAGULANT THERAPY IN SURGERY ICD implanted patients: balance between Benefit & Complication Before Coronary Artery By-pass Surgery After Coronary Artery By-pass Surgery In Extracardiac Surgery Interactive Focus on Etna Room Do we need CardiopulmOnary Test in All Heart Failure patients? Double Antiplatelet Therapy in association with Oral Anticoagulation Interactive Sympsosium Etna Room Atrial Fibrillation & Heart Failure 50 51
28 TRAINING COURSE ON Cardiology and Intensive Care FOR ALLIED PROFESSIONALS APRIL 18-19, (Italian Allied Professionals only) Program Chairs: Giuseppina Maura Francese Angelo Gambera Loredana Morichelli President: Michele M. Gulizia, MD, FESC 52 53
29 TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care Aprile Saturday, April 18 Saturday, April 18 Calipso Room Calipso Room 9.00 Registration of participants 9.15 Greetings from the President and the Program Chairs NURSING MANAGEMENT OF CARDIOVASCULAR DRUGS 9.30 To ensure therapeutic procedures: Nurse responsibilities 9.45 Risk management in therapy administration Nursing management in Cardiology The predictable risk in drug management Discussion ORGANIZATIONAL ASPECTS AND MANAGEMENT IN ARRHYTHMOLOGY Nursing Research Risk management in arrhythmology Nurse in quality control NURSING IN HEMODYNAMIC The cath lab: equipment and organizational model Nursing care during hemodynamic procedures Nursing care before and after procedures Discussion UPDATE IN ELECTROPHYSIOLOGY AND CARDIAC PACING Management of cardiac implantable devices during ablation procedures or surgery MRI conditional implantable devices: what to do before, during and after scanning Inappropriate and unnecessary shocks. How to prevent them? News and perspectives in electrophysiology Discussion The informed consent 54 55
30 TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care Aprile Saturday, April 18 Sunday, April 19 Calipso Room Calipso Room PREVENTION OF INFECTION IN CARDIOLOGY AND CARDIAC SURGERY Definition of infection related to care practices Risk factors Monitoring systems and survey Prevention Strategies Discussion NAO IN NONVALVULAR ATRIAL FIBRILLATION 9.00 Non-valvular atrial fibrillation: how to define it? 9.15 Thromboembolic and hemorrhagic risk stratification 9.30 The new oral anticoagulants: a valuable opportunity for therapy tailoring 9.45 Monitoring of anticoagulant activity and management of bleeding Discussion JOINT SESSION: EDUCATION AS A TOOL TO ENHANCE THE HEALTH CARE ALLIED PROFESSIONALS The Educational Dossier The Residential Education On-the-job Training The FAD Education Discussion 56 57
31 TRAINING COURSE FOR ALLIED PROFESSIONALS Cardiology and Intensive Care Aprile Sunday, April 19 Sunday, April 19 Calipso Room Calipso Room NURSE AND HEART FAILURE NURSING CARE IN NON-INVASIVE VENTILATION What is the nurse role in diagnostic and therapeutic pathways during the patient hospital stay Continuity of care after discharge: nurse role during the follow-up The terminal patient: symptom and pain control. Is it possible to switch off the automatic implantable defibrillator? Health education and counseling. What communication tools for patients and their relatives 13,00 Discussion Acute respiratory failure Non-invasive ventilation: theoretical aspects and indications CPAP AND BPAP Nursing care to the patient in non-invasive ventilation Discussion LECTURE A defibrillator to bring down mortality: state of the art (S-ICD) 58 59
32 Basic Life Support Course and Defibrillation APRIL 20, 60 61
33 BLS-D COURSE FOR ALLIED PROFESSIONALS 20 Aprile Monday, April 20 Monday, April Course registration INTRODUCTION - SLIDES: Survival Chain Adults early defibrillation - BLS-D algorithm Pediatric early defibrillation - (differences) CPR ADULTS: Check the state of consciousness CPR Protective equipment Chest compressions Gasping and safety lateral positioning Breathing without chest compressions CPR and two rescuers Airway obstruction Heimlich manouvres Calipso Room CPR ON INFANTS: Pediatric CPR Survival Chain Rescue breathing Subdislocation of the jaw Chest compression Airway obstruction Differences in infant and child Training on mannequins adults, infant and child Final evaluation: theoretical and practical skills Training on mannequins adults Lunch break Calipso Room Break 62 63
34 INFORMATION General Scientific Registration Payment Congress Venue Hotel Practical 64 65
35 GENERAL INFORMATION CONGRESS VENUE SHERATON CATANIA HOTEL & CONFERENCE CENTER Via Antonello da Messina, Aci Castello - Catania (CT) Tel Fax SCIENTIFIC SECRETARIAT MICHELE M. GULIZIA Cardiology Division - Garibaldi-Nesima Hospital Via Palermo, Catania, Italy Tel Fax michele.gulizia@alice.it ORGANIZING SECRETARIAT ADRIA CONGREX Via Sassonia, Rimini, Italy Tel Fax info@mcmweb.it - Web site: VISA REQUIREMENTS An official invitation letter for visa may be requested to the Organizing Secretariat. This invitation will not imply any obligation from the Organization to provide any kind of financial contribution. SECRETARIAT AND REGISTRATION DESK OPENING HOURS For Groups April 17, 2.30 pm pm For appointment please contact the Organizing Secretariat For Individuals April 18, 8.00 am pm April 19, 8.00 am pm April 20, 8.00 am pm OFFICIAL LANGUAGES The Meeting official languages are English and Italian with simultaneous translation. EXHIBITION The technical and pharmaceutical exhibition area will be located at the Congress Venue, close to the conference rooms. The exhibition opening hours will follow the timetable of the scientific sessions. Companies that are interested in presenting their products or taking up other sponsorship options can contact the Organizing Secretariat, Adria Congrex
Clinical & Interventional Cardiology
Endorsed by CATANIA APRIL 18-20 ITALY Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC PRELIMINARY PROGRAM 1 Dear Colleagues and Friends, I would like to invite you to attend
More informationCARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM
Sesto San Giovanni PRELIMINARY PROGRAM PRESIDENTS Sesto San Giovanni G. J. Klein University Hospital Card Inv Unit London Ontario Canada A. S. Montenero IRCCS Multimedica Cardiology Dpt. Sesto San Giovanni
More informationClinical & Interventional Cardiology
Endorsed by Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC ADVANCE PROGRAM 1 PRESIDENT Michele M. Gulizia, MD, FESC Honorary Presidents Antonio G. Circo Salvatore Mangiameli
More informationClinical & Interventional Cardiology
Endorsed by Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC Final Program 1 PRESIDENT Michele M. Gulizia, MD, FESC HONORARY PRESIDENTS Antonio G. Circo Salvatore Mangiameli
More informationSyncope Unit Project A prospective systematic guideline-based evaluation and treatment of patients referred to the Syncope Units of general hospitals
AIAC Associazione Italiana Aritmologia e Cardiostimolazione Syncope Unit Project Syncope Unit Project A prospective systematic guideline-based evaluation and treatment of patients referred to the Syncope
More informationRome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE
Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)
More informationInternational Workshop ANTITHROMBOTIC THERAPY IN ACUTE CORONARY SYNDROMES. Villa Olmo - Como
International Workshop ANTITHROMBOTIC THERAPY IN ACUTE CORONARY SYNDROMES Villa Olmo - Como 24-25 February 2012 Scientific Secretary Diego Ardissino, M.D. Unità Operativa di Cardiologia Dipartimento Assistenziale
More informationCATANIA CANDIDATE CITY 12th FINA WORLD SWIMMING CHAMPIONSHIPS (25m) 2014
CATANIA CANDIDATE CITY 12th FINA WORLD SWIMMING CHAMPIONSHIPS (25m) 2014 14th December 2010 CATANIA 2014 The choice to candidate Sicily and Catania in particular for the 12 th FINA World Swimming Championships
More informationAtrial fibrillation and heart failure: the ugly and the nasty
Atrial fibrillation and heart failure: the ugly and the nasty February 21-22 Bologna - Italy Royal Hotel Carlton Program PRESIDENT Alessandro Capucci, MD Cardiology Clinic Università Politecnica delle
More informationEFG Summer Council Meeting May 31 - June 1, 2014
Workshop Geologists of Europe in the 3 rd millennium May 29-30, 2014 EFG Summer Council Meeting May 31 - June 1, 2014 Palermo (Italy) A N N O U N C E M E N T 1 The Consiglio Nazionale dei Geologi - Italian
More informationHot Line Session at European Society of Cardiology (ESC) Congress 2014:
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Once-Daily
More informationNovel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant
More informationJeffrey M. Carlton Heart & Vascular Institute Presents
Jeffrey M. Carlton Heart & Vascular Institute Presents 6 th ANNUAL CARDIOLOGY UPDATE: NEW DEVELOPMENTS Program Director: Robert and Georgia Roth Endowed Chair for Excellence in Cardiac Care Saturday, September
More informationtrial Fibrillation 2009
ATRIAL FIBRILLATION IX INTERNATIONAL MEETING trial Fibrillation 2009, ATRIAL FIBRILLATION IX INTERNATIONAL MEETING 2 IX INTERNATIONAL MEETING PRESIDENT Alessandro Capucci, MD Cardiology Clinic, Ospedali
More information21st Annual OSF Cardiovascular Symposium
21st Annual OSF Cardiovascular Symposium new waves in cardiac electrophysiology saturday 18 october 2014 7:00 a.m. 4:00 p.m. embassy suites conference center east peoria, illinois OBJECTIVES Overall Program:
More informationBreakfast symposium: From hospital to home - the focus on the patient
Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee
More informationCURRICULUM VITAE Prof. ANTONIO CURNIS
CURRICULUM VITAE Prof. ANTONIO CURNIS I. Personal Informations - Born in February 11 th 1958 in Bergamo (Italy). - Graduated by University of Brescia 23.10.88 - Division of Cardiology of Civil Hospital
More informationCardiology Update 2014
Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. The
More informationBayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media
News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban
More informationContemporary Management of Cardiovascular Disease
Contemporary Management of Cardiovascular Disease FRIDAY, OCTOBER 30, 2015 Baltimore Hilton Hotel Baltimore, Maryland Register Today! ccfcme.org/gocvddc Contemporary Management of Cardiovascular Disease
More informationThe Copernican Revolution in Ischemic Heart Diseases: the day after
Menarini Foundation Symposia: 249 The Copernican Revolution in Ischemic Heart Diseases: the day after Pisa (Italy), June 27 th 28 th, 2014 Organized by POSTGRADUATE SCHOOL OF CARDIOVASCULAR MEDICINE UNIVERSITY
More informationPRIX ITALIA HOTELS FOR ITALIAN AND FOREIGN DELEGATES
PRIX ITALIA HOTELS FOR ITALIAN AND FOREIGN DELEGATES Once the delegates have chosen the hotel, they should get in touch with SOGECOM to arrange for bookings. The NUMBERS and NAMES are: Maria Tondini -
More informationAntiplatelet and Antithrombotics From clinical trials to guidelines
Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories
More informationMediterranean School of Oncology
Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus
More informationMedical Tourism - The Role of Intervals inCardiovascular Cancer
Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)
More informationon End Stage Focus on Idiopathic
II International Conference on End Stage Lung DiseaseS: Focus on Idiopathic Pulmonary Fibrosis Padua - Italy, February 22 nd, 2013 Palazzo del Bo - Aula Nievo ENDORSEMENTS WELCOME TO PADUA Italian Association
More informationPRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy)
PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy) Organizing Scientific Committee: Executive Committee of Italian Society for Vascular Investigation L. Aluigi T. Baroncelli
More informationAtahotel Executive Milan, Italy October 21, 2011
www.ecmo2011.org N E W P E R S P E C T I V E S I N ECMO2011 II INTERNATIONAL MEETING JOIN US FROM YOUR SMARTPHONE! Under the Auspices of Atahotel Executive Milan, Italy October 21, 2011 PRELIMINARY PROGRAM
More informationMinimally Invasive Cardiac Surgery
3rd Annual Bakken Symposium Minimally Invasive Cardiac Surgery December 7 & 8, 2009 Mayo Auditorium, COURSE DIRECTORS: Kenneth K. Liao, MD, PhD James D. St. Louis, MD Presented by Department of Surgery
More informationPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More informationAmerican College of Allergy, Asthma & Clinical Immunology (ACAAI), USA International Center for Interdisciplinary Studies of Immunology Washington
3 rd International Symposium: New Horizons in Treatment Modalities for Allergic & Immunologic Diseases SCIENTIFIC PROGRAM October 3-4, 2008 NH Laguna Palace, Mestre Venice, Italy Organized in cooperation
More informationAtrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital
Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial
More informationHeart Failure: From Prevention to Intervention
Sharp HealthCare Presents Heart Failure: From Prevention to Intervention Saturday, May 16, 2015 DoubleTree by Hilton Hotel San Diego - Mission Valley San Diego, Calif. As medical professionals, we know
More informationFIBRILLATION ATRIAL 12 INTERNATIONAL. Atrial Fibrillation and Heart Failure: MEETING. Preliminary Program
Xxxxxxxxxxxxxxxx Atrial fibrillation and heart failure: February r 16/17, Atrial Fibrillation and Heart Failure: Preliminary Program February 16/17, Royal Hotel Carlton Bologna - Italy 1 PRESIDENT Alessandro
More informationChristopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
More informationMagna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA.
Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA June 25-26, 2013 University Campus Salvatore Venuta,Catanzaro,Italy Building H,
More information58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement
SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo
More informationPARKINSON S DISEASE MULTIPLE DOMAINS
PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (5) Quinta scuola estiva di Neuroscienze (5) July 7-13, 2007 PARKINSON S DISEASE MULTIPLE DOMAINS Catania Parco degli
More informationThe largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
More informationfriday 30 may 2008 brussels belgium Sheraton Brussels Hotel Place Rogier 3 Rogierplein B- 1210 Brussels
friday 30 may 2008 brussels belgium 1 ST Belgian Congress on Acute Cardiac Care Sheraton Brussels Hotel Place Rogier 3 Rogierplein B- 1210 Brussels Dear Colleagues, On behalf of the Belgian Interdisciplinary
More informationCARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
More informationMUSCULOSKELETAL ONCOLOGY COURSE
MUSCULOSKELETAL ONCOLOGY COURSE A Course of University of Padova Department of Orthopedics and Orthopedic Oncology September 16 18, 2016 MESTRE (Venezia, Italy) This is the first edition of the Musculoskeletal
More informationHaploidentical Stem Cell Transplantation
UNIVERSITÀ DEGLI STUDI DI PARMA Preliminary Program 8 th International Symposium on Haploidentical Stem Cell Transplantation Chairman Co-Chairpersons Massimo F. Martelli, Yair Reisner Parma 4-6 September
More informationCARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE
CARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE Maarten L Simoons Thoraxcenter Erasmus MC Rotterdam President ESC 2000-2002 Cardiology, the next 10 years (?) Break through of genetics cardiomyopathy, ion channel
More informationBASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
More information7th annual ConFerenCe location
Sponsors 7th Annual WOMEN and Ischemic Heart Disease Symposium Friday, April 19, 2013 Offered in cooperation with the California Chapter of the American College of Cardiology and WomenHeart: The National
More informationRx Updates New Guidelines, New Medications What You Need to Know
Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact
More informationCardiac Rhythm Device Summit:
Division of Cardiovascular Diseases Cardiac Rhythm Device Summit: Implantation, Management, and Follow Up June 17-19, 2016 Swissotel Chicago Course Directors: LEARN. ADVANCE. CONNECT. celinks.mayo.edu/cardiacdevice2016
More informationNew Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Late-Breaking Science at ESC Congress 2015: New Real-World Evidence Reaffirms
More informationSTROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:
STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention
More informationAdvanced Cardiac Life Support Provider & Provider Renewal Courses (ACLS & ACLS-R)
Advanced Cardiac Life Support Provider & Provider Renewal Courses (ACLS & ACLS-R) Baptist Health is an authorized American Heart Association (AHA) provider and has approved these courses for Continuing
More informationSurvey of Current Issues in Surgical Anesthesia
Survey of Current Issues in Surgical Anesthesia November 30 December 4, 2015 The Ritz-Carlton Golf Resort Naples, FL Symposium Directors Professor of Anesthesiology Lerner College of Medicine of Case Western
More informationSTROKE PREVENTION IN ATRIAL FIBRILLATION
STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients
More informationINTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015
LS LS Magna Gr ae cia University of Catanzaro, Italy Preliminary Program PhD PROGRAMME PhD PROGRAMME MOLECULAR AND TRANSLATIONAL ONCOLOGY LIFE SCIENCES ORGANIZING COMMITTEE Professor Ennio Carbone Head
More informationCENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL
Outline of Cardiology Training Chapter 6 Article 1 CENTRAL MONITORING AUTHORITY for CARDIOLOGY at EU LEVEL 1.1. The central monitoring authority for the specialty will be the European Board for the Specialty
More informationSECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, 2012. Cardiovascular Center OLV Clinic Aalst Belgium. and
SECOND CARDIOLOGY JOINT SEMINAR Rome, April 12-13, 2012 Cardiovascular Center OLV Clinic Aalst Belgium and Cardiology Faculty of Medicine and Psychology Sapienza University, Rome, Italy Cardiology Sacred
More informationDorset Cardiac Centre
P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February
More informationWhat Are Arrhythmias?
What Are Arrhythmias? Many people have questions about what the word arrhythmia means, and arrhythmias can be a difficult subject to understand. The text below should give you a better understanding of
More informationPRECHTL S METHOD OF QUALITATIVE ASSESSMENT OF GENERAL MOVEMENTS
Department of Gynaecology, Obstetrics and Paediatrics Division of Neonatology Head: Prof. F. Ferrari Azienda Ospedaliera, Policlinico di Modena The GM -Trust Pollicino Associazione per il Progresso, della
More informationHERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below
Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications
More informationCARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014 Participating Faculty Hector O. Ventura, MD, FACC Section Head, Cardiomyopathy and
More informationUpdate on Indications, Techniques and Controversies for Lead Extraction
Update on Indications, Techniques and Controversies for Lead Extraction W Boston 100 Stuart Street, Boston, MA Course Directors Avi Fischer, MD Laurence M. Epstein, MD Brigham and Women s Hospital Sponsored
More informationHow To Get A Dose Of Bayer Healthcare'S Oral Anticoagulant, Xarelto
News Release FOR UK HEALTHCARE MEDIA ONLY Bayer HealthCare Bayer plc Bayer House Strawberry Hill Newbury Berkshire, RG14 1JA www.bayer.co.uk Bayer s Xarelto (rivaroxaban) Recommended by CHMP for EU Approval
More informationFailure or significant adverse effects to all of the alternatives: Eliquis and Xarelto
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
More informationAtrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
More informationATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
More informationEMA Reaffirms Positive Benefit-Risk Balance of Bayer s Xarelto for Stroke Prevention in Patients with Atrial Fibrillation
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com EMA Reaffirms Positive Benefit-Risk Balance of Bayer s Xarelto for Stroke Prevention
More informationBayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of
More informationPARTNER PROSPECTUS. ROME November 18th/20th - 2015 Palazzo Colonna
PARTNER PROSPECTUS ROME November 18th/20th - 2015 Palazzo Colonna PLACE NOT JUST AN EVENT BUT... A PLACE, TOO PLACE A COMMUNICATION PLATFORM PLACE 2015 is a platform of laboratories aimed at progress in
More informationPresenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands
Comparing zotarolimus-eluting and bare-metal stent efficacy in selected high bleeding risk patients treated with a short dual antiplatelet therapy duration. A pre-specified analysis from the The Zotarolimuseluting
More informationNew Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel
New Frontiers in Glaucoma Management Rome, 7 February 2014 Donna Camilla Savelli Hotel FACULTY Marco Centofanti University of Rome Tor Vergata Head of Glaucoma Research Line IRCCS - Fondazione Bietti Rome
More informationPractical Information for Participants
Union for the Mediterranean High Level Conference on the financing of the future Trans-Mediterranean Transport Network (TMN-T) 'Porto di Roma' (Civitavecchia), 9 & 10 December 2014 Practical Information
More informationSECTION I: Request. SECTION II: Need. Program Description
SECTION I: Request This is a formal request for the Utah CARMA Center to be formally recognized by the University of Utah as a large, collaborative medical and academic center whose focus is on comprehensive
More informationScientific Topics. Committees. Invited International Organizing Committee
First Bulletin March 2014 5 th Roma International Conference on Astroparticle Physics (RICAP-14) September 30 th October 3 rd, 2014 Noto, Italy Hosted by Laboratori Nazionali del Sud, INFN - Catania RICAP-14
More informationOPA Continental Cup 2008
I N V I T A T I O N A/To: OPA- National Ski Associations Mr. Georg Zipfel, Technical Delegate FIS Mr. Giuseppe Brigadoi, Nat. Assistant TD FIS Mr. Aldo Plai, OPA-COC Coordinator Italy FIS Nordic Office
More informationSPEAKERS AND CHAIRMEN
44 th COURSE ON ADVANCES IN NEPHROLOGY, DIALYSIS AND TRANSPLANTATION Milan, December 6-9, 2012 Centro Congressi Milan Marriott Hotel Via Washington, 66 - Milan Directors of the Course G. D'AMICO - P. MESSA
More informationINTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
More informationContemporary Management of Cardiovascular Disease
Contemporary Management of Cardiovascular Disease NOVEMBER 20 21, 2015 Hilton Anatole Hotel Register Today! ccfcme.org/gocvdtx Contemporary Management of Cardiovascular Disease Join us on November 20-21
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
More informationChronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure
Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure Gaetano M. De Ferrari, MD Dept. of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy for the CardioFit
More informationA C C O M M O D A T I O N S D I R E C T I O N S. Exhibitor tables will be accessible at 7:30 a.m.
R E g I S T R AT I O N I N F O R M AT I O N There is a $55 fee for Christiana Care Health System (CCHS) employees ($75 day of registration, if seating permits), $75 fee for non-cchs employees ($95 day
More informationBrooklyn Stroke Symposium 2015
Brooklyn Stroke Symposium 2015 May 28, 2015 Brooklyn Public Library Grand Army Plaza Sponsored by Keynote Presentations Sleep Apnea and Stroke: More than a Snore Devin L. Brown, M.D., M.S. Professor of
More informationKevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013
Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness
More informationBayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment
More informationNew Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationViaggiatori della vita Reiseveranstalter für Italien
Viaggiatori della vita Reiseveranstalter für Italien CULTURAL JOURNEY TO ITALY ITALY 1st Travel Day: Flight to Rome Transfer from the airport to the 4-Stars-Hotel [first overnight stay at Rome] 2nd Travel
More informationStent for Life Initiative How can we improve system delay and patients delay in STEMI
Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration
More informationCARDIAC CARE. Giving you every advantage
CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The
More informationSEEC2012 Lecce -Information
SEEC2012 Lecce -Information 1. Summer School Venue The X edition of the Summer School in Applied Macroeconometrics Programming in MatLab (SEEC 2012) will be held at the Department of Economics and Quantitative
More informationSPONSORSHIP/ADVERTIZING OPPORTUNITIES
SPONSORSHIP/ADVERTIZING OPPORTUNITIES 30 th Conference of the European Colloid and Interface Society Rome, 4-9 September 2016 SPONSORSHIP/ADVERTIZING OPPORTUNITIES We invite you to take advantage of this
More informationIntroduction. Methods. Study population
New Technologies, Diagnostic Tools and Drugs Schattauer 2012 1 Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a real world atrial fibrillation
More informationRome, 12-14 May 2016
Preliminary Program The International Working Group on Maternal Hemodynamics invites you to the Second International Congress on Maternal Hemodynamics Venue: Residenza di Ripetta, Via di Ripetta, 231 -
More informationMedTASS 2013 12-13 3 MEDITERRANEAN TRANSPLANTATION ANESTHESIOLOGY AND SIMULATION SYMPOSIUM. Villa Igiea - PALERMO. April 2013.
MedTASS 2013 rd 3 MEDITERRANEAN TRANSPLANTATION ANESTHESIOLOGY Villa Igiea - PALERMO th th 12-13 April 2013 1 MedTASS 2013 MedTASS 2013 Dear colleagues, It is our honor and privilege to invite you to the
More informationSAPIENZA UNIVERSITA DI ROMA UNIVERSITY OF CALIFORNIA SAN DIEGO FIRST ANNUAL CONFERENCE ON TRANSLATIONAL RESEARCH IN MEDICINE
SAPIENZA UNIVERSITA DI ROMA UNIVERSITY OF CALIFORNIA SAN DIEGO FIRST ANNUAL CONFERENCE ON TRANSLATIONAL RESEARCH IN MEDICINE May 7-9, 2009 Sant Andrea Hospital, Rome Dear Colleagues, The First Annual Conference
More information3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin.
To Clot or Not What s New In Anticoagulation? Anita Ralstin, MS CNS CNP 1 Clotting Cascade 2 Anticoagulant drug targets Heparin XI VIII IX V X VII LMWH II Warfarin Fibrin clot 1 Who Needs Anticoagulation
More informationInternational Course in Football Management
International Course in Football Management April 23 rd May 18 th 2012 ITALIAN FOOTBALL ASSOCIATION Technical Center Coverciano (Florence) The Italian Football Association (Federazione Italiana Giuoco
More informationCardiology ARCP Decision Aid August 2014
Cardiology ARCP Decision Aid August 2014 The table that follows includes a column for each training year which documents the targets that have to be achieved for a satisfactory ARCP outcome at the end
More informationInnovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
More information